We analyzed 333 cases of HER2 status in another FFPE block from the same tumor with double-equivocal HER2 in initial specimens identified from 5685 invasive primary breast cancers according to the 2013 ASCO/CAP guidelines. The gene discussed is ERBB2; the disease is neoplasm.